{"id":216494,"date":"2021-06-17T08:39:31","date_gmt":"2021-06-17T08:39:31","guid":{"rendered":"https:\/\/scienze.fanpage.it\/?p=215862"},"modified":"2021-06-17T08:39:31","modified_gmt":"2021-06-17T08:39:31","slug":"vaccino-covid-di-curevac-delude-le-aspettative-efficace-solo-al-47","status":"publish","type":"post","link":"https:\/\/nugnes.com\/?p=216494","title":{"rendered":"Vaccino Covid di CureVac delude le aspettative: efficace solo al 47%"},"content":{"rendered":"<img src=\"https:\/\/static.fanpage.it\/wp-content\/uploads\/sites\/5\/2020\/04\/vaccinoinsviluppo-638x425.jpg\" \/><br \/>La societ\u00e0 biofarmaceutica tedesca CureVac ha annunciato che il suo vaccino anti Covid a RNA messaggero \"CVnCoV\" ha un'efficacia del 47 percento contro la malattia sintomatica di qualsiasi gravit\u00e0. Un risultato che, seppur intermedio e non definitivo, delude le aspettative. A influenzarlo l'elevata circolazione di varianti.<br \/><a href=\"https:\/\/scienze.fanpage.it\/vaccino-covid-di-curevac-delude-le-aspettative-efficace-solo-al-47\/\">Continua a leggere<\/a>","protected":false},"excerpt":{"rendered":"<p>La societ\u00e0 biofarmaceutica tedesca CureVac ha annunciato che il suo vaccino anti Covid a RNA messaggero &#8220;CVnCoV&#8221; ha un&#8217;efficacia del 47 percento contro la malattia sintomatica di qualsiasi gravit\u00e0. Un risultato che, seppur intermedio e non definitivo, &#8230;<\/p>\n","protected":false},"author":101,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-216494","post","type-post","status-publish","format-standard","hentry","category-salute"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/216494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/users\/101"}],"replies":[{"embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=216494"}],"version-history":[{"count":1,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/216494\/revisions"}],"predecessor-version":[{"id":216495,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/216494\/revisions\/216495"}],"wp:attachment":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=216494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=216494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=216494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}